Prestwick Chemical
Records under this name other than patents Prestwick Chemical holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Prestwick Chemical
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,331,022 | Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors Formerly held In force · High confidence | In force | High confidence | |
| US 8,088,795 | Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 Formerly held Lapsed on the fee record Ended Jan 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2024 | From the USPTO record |
| US 8,962,627 | Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors Formerly held Lapsed on the fee record Ended Feb 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2023 | From the USPTO record |
| US 7,834,016 | Inhibitors of the interaction between MDM2 and p53 Formerly held Lapsed on the fee record Ended Nov 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2022 | From the USPTO record |
| US 7,514,454 | PIPERIDIN-2,6-Dione Pamoate Salts and Their Use for the Treatment of Stress-Related Affective Disorders Formerly held Lapsed on the fee record Ended Apr 7, 2017 · High confidence | Lapsed on the fee record | Ended Apr 7, 2017 | High confidence |